A Phase 1 Study of LY2787106 in Cancer and Anemia
NCT01340976
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Anemia
Interventions
DRUG:
LY2787106
DIETARY_SUPPLEMENT:
Iron Supplementation
Sponsor
Eli Lilly and Company